Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02797756 · ClinicalTrials.gov registry record

Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
35
Enrollment target

NCT02797756 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02797756 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
35 participants
Enrollment target

Study Summary

Using an active cohort of children in whom Airway and gastrointestinal endoscopy will be performed, investigators will conduct a chart review to obtain relevant clinical data and the investigators will use an aliquot of airway sample obtained during the clinically indicated bronchoscopy for microbiome analysis. A case-control study design will be used to study whether subjects with CC with GER have a distinct lung microbiome and increased inflammation as compared with subjects with CC without GER and to determine whether the microbiome and degree of inflammation is related to the type of GER (acidic versus nonacidic).

Interventions

  • PROCEDURE Esophago-gastro-duodenoscopy (EGD) with biopsy
  • PROCEDURE Esophageal Impedance Monitoring (EIM)

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2014-08-05
Est. Completion 2018-12-12

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02797756

The ClinicalTrials.gov registry entry for NCT02797756 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Esophago-gastro-duodenoscopy (EGD) with biopsy is the first listed.

NCT02797756 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02797756 about?

NCT02797756 is a clinical study titled "Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough". Using an active cohort of children in whom Airway and gastrointestinal endoscopy will be performed, investigators will conduct a chart review to obtain relevant clinical data and the investigators will use an aliquot of airway sample obtained during the clinically indicated bronchoscopy for microbio...

What is the current status of trial NCT02797756?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2014-08-05. Estimated completion is 2018-12-12.

What interventions are being tested in trial NCT02797756?

The interventions under investigation include: Esophago-gastro-duodenoscopy (EGD) with biopsy (PROCEDURE), Esophageal Impedance Monitoring (EIM) (PROCEDURE).

Who is sponsoring clinical trial NCT02797756?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.